Aflac price target raised to $106 from $105 at Evercore ISI

Evercore ISI raised the firm’s price target on Aflac (AFL) to $106 from $105 and keeps an Underperform rating on the shares. The firm raised its second half EPS and Japan sales estimates following “a strong sales quarter” from the Japanese operation in Q2 and better than expected net interest income. However, the sustainability of the new cancer product sales “will be a key focus” and there will likely be a fade following the initial wave of reselling the existing customer base, the analyst added.